Showing results (201-210 of 212) with videos related to
Sort By:
Pageof 22
JCO Oncology Advances|February 5, 2025
State of Professional Well-Being, Satisfaction, and Career Plans Among US Oncologists in 2023Caroline Schenkel, Laura A Levit, Kelsey Kirkwood, et al.Blood|April 19, 2013
Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLLAnna Vardi, Antonis Dagklis, Lydia Scarfò, et al.Scientific Reports|October 22, 2024
Burnout and turnover risks for healthcare workers in the United States: downstream effects from moral injury exposureTimothy J Usset, Lucas D Baker, Brandon J Griffin, et al.Cancer|October 22, 2025
Overall side-effect bother consistently associated with early treatment discontinuation due to adverse events in four clinical trials with various cancer types and treatmentsJohn Devin Peipert, Shaili Ganatra, Fengmin Zhao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2006
Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disordersAnne J Novak, Deanna M Grote, Steven C Ziesmer, et al.JAMIA Open|June 15, 2026
Patient perspectives on clinicians' use of ambient AI scribesShreya J Shah, Kirsten Naumann Murtagh, Danton Char, et al.Blood Cancer Journal|August 29, 2025
State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop CommitteeChristine E Ryan, Inhye E Ahn, Aswin Sekar, et al.Leukemia|September 11, 2024
The non-canonical BAF chromatin remodeling complex is a novel target of spliceosome dysregulation in SF3B1-mutated chronic lymphocytic leukemiaDaniel Hägerstrand, Blaž Oder, Diego Cortese, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 13, 2026
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026William G Wierda, Jennifer Brown, Jeremy S Abramson, et al.Blood|January 31, 2015
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerationsPanagiotis Baliakas, Andreas Agathangelidis, Anastasia Hadzidimitriou, et al.Pageof 22